Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study

Gatell, José M.INSIGHT STALWART Study Group2016-03-032016-03-0320101932-6203https://hdl.handle.net/2445/96104The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4+ counts compared to no therapy.9 p.application/pdfengcc-by (c) Gatell, José M. et al., 2010http://creativecommons.org/licenses/by/3.0/esAntiretroviralsVIH (Virus)Antiretroviral agentsHIV (Viruses)Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART studyinfo:eu-repo/semantics/article6108312016-03-03info:eu-repo/semantics/openAccess20186278